Months Year-end Unaudited but Review Audited 30 September 2019 31 March 2019 Net Profit (Loss) INR. (43,007,441) (65,497,534) Net Profit (Loss) per share INR. (1.36) (2.07) 5. Opinion of the Committee and
Year-end Unaudited but Review Audited 30 September 2019 31 March 2019 Net Profit (Loss) Indian Rupee (43,007,441) (65,497,534) Net Profit (Loss) per share Indian Rupee (1.36) (2.07) 5. Opinion of the
Osotspa Public Company Limited Q4’18 and FY18 Management Discussion & Analysis 27 February 2019 Q4’18 and 2018 Management Discussion & Analysis Page 1/7 Financial Highlights - Q4’18 Net profit* was
117.95 million Long-term loan from financial institutions increase by Baht 34.51 million Employee benefit obligations increase by Baht 10.03 million Shareholders’ Equity Net operating profit for the period
% Change Amount % Amount % Amount % Q1-21 VS Q1-20 Q1-21 VS Q4-20 Sales revenue 19,039 100.0 12,755 100.0 18,498 100.0 49.3 2.9 Gross profit 4,103 21.6 2,586 20.3 4,067 22.0 58.7 0.9 Operating profit 1,372
financial statements for the three-month period ended June 30, 2019. The Group's sales and net profit totaled Bt2,992.8 million and Bt159.0 million, respectively, compared to Bt3,643.3 million and Bt558.0
recorded income incurred from deferred tax for the amount of THB 28.6 million. The net amount after amortization was 27.6 million in the first 6-month period of 2017 Operation : Consolidated Profit & Loss
%, respectively. The higher ratio on a period-on-period basis was attributable to the Company having some costs in depreciation, utility expenses, and the Company recognized the additional past-employment benefit
bill amount per patient. Operation : Consolidated Profit & Loss Statement 4Q 4Q % 12 mth 12 mth % Unit : THB million 2017 2016 change 2017 2016 change Revenue from non-social security 197.87 182.46 8
from employee benefit according to the Labor Protection Act (No. 7) B.E. 2562 in the amount of THB 39.60 million. As a result the Company's net profit margin to total revenues decreased from 5.00 percent